Aiming to enhance tumor cell uptake while reducing toxicity on normal tissues, we have developed a multimeric and self-assembled CXCR4- targeted protein-based nanoparticle for the selective delivery of toxins 11. The gene discussed is CXCR4; the disease is neoplasm.